G-CSF does not worsen toxicities and efficacy of CAR-T cells in refractory/relapsed B-cell lymphoma.
Eugenio GalliVincent AllainRoberta Di BlasiSophie BernardLaetitia VercellinoFlorence MorinHannah MoattiSophie Caillat-ZucmanSylvie ChevretCatherine ThieblemontPublished in: Bone marrow transplantation (2020)